Search clinical trials for: Glucagonlike peptide

Total 2250 results

Alcresta Therapeutics, Inc.

Completed

Safety, Tolerability and Fat Absorption Using Enteral Feeding In-line Enzyme Cartridge (Relizorb)

Exocrine Pancreatic Insufficiency

United States
Shengjing Hospital

Enrolling by invitation

rhBNP in Type 3 Pulmonary Hypertension

Group 3 Pulmonary Hypertension

China
European Organisation for Research and Treatment...

Completed

Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer

Cervical Cancer

Norway, Germany, United Kingdom, Sweden, Austria, France, Netherlands
Henan Institute of Cardiovascular Epidemiology

Not yet recruiting

Effect of rhBNP on CMD in Patients With STEMI After PPCI

STEMI
Mayo Clinic
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health... and other collaborators

Completed

Human Brain Natriuretic Peptide (BNP) (or Nesiritide) to Help Heart, Kidney and Humoral Function.

Left Ventricular Diastolic Dysfunction

United States
Horng Chen
National Heart, Lung, and Blood Institute (NHLBI); American Heart Association; National Center for Research Resources (NCRR) and other collaborators

Completed

Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart Failure (SubqBNP)

Congestive Heart Failure | Cardiomyopathy

United States
Rousselot BVBA
BioTeSys GmbH

Completed

Impact of the Source and Food Matrices on the Bioavailability of Peptan® (Collagen Peptides) in Healthy Subjects

Bioavailability

Germany
Wageningen University
Unilever R&D

Completed

LACTOPRES:Study on the Effect of Dairy Peptides on Blood Pressure in Untreated Hypertensive Subjects.

Hypertension

Netherlands
University of California, Davis
National Cancer Institute (NCI); IO Biotech

Recruiting

IDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant, Non-Muscle Invasive Bladder Cancer

Stage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma

United States
Boehringer Ingelheim

Completed

Evaluating Comparative Effectiveness of Empagliflozin in Type 2 Diabetes Population With and Without Chronic Kidney Disease

Diabetes Mellitus, Type 2

United States
University of Virginia
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Melanoma (Skin)

United States
Near East University, Turkey

Completed

Serum Levels of C Type Natriuretic Peptide in Different Reproductive Periods (CO)

Healthy Postmenopausal Women | Serum CNP Levels | Healthy Reproductive Age Women | Healthy Perimenopausal Women

Cyprus
Janssen Research & Development, LLC

Completed

Cardiovascular Outcomes in Participants With Type 2 Diabetes Mellitus (T2DM)

Diabetes Mellitus, Type 2

United States
Peking University Cancer Hospital & Institute

Not yet recruiting

First Human Trial of Targeting MDM2/MDMX PET Imaging

Nuclear Medicine | MDM2/MDMX Gene Mutation | Positron Emission Tomography Imaing
Lene Meldgaard Knudsen
IO Biotech

Terminated

PD-L1 Peptide Vaccination in High Risk Smoldering Multiple Myeloma

Smoldering Multiple Myeloma

Denmark
Yonsei University

Unknown

A Clinical Trial of Silk Peptide for the Evaluation of Efficacy on Immune Function

Normal Healthy Subjects

Korea, Republic of
Hadassah Medical Organization
Vaxil Therapeutics Ltd.

Withdrawn

A Novel Vaccine for the Treatment of MUC1-expressing Tumor Malignancies

Multiple Myeloma | Tumors

Israel
University of Texas Southwestern Medical Center
Scios, Inc.

Completed

Impact of Nesiritide Infusion for Decompensated Heart Failure in the Emergency Department

Heart Failure, Congestive | Cardiomyopathy

United States
Lene Meldgaard Knudsen

Completed

Vaccination With PD-L1 Peptide Against Multiple Myeloma

Multiple Myeloma

Denmark
Peking University
Sun Yat-sen University; China-Japan Union Hospital, Jilin University

Completed

Integrin α6-targeted SPECT Imaging of Breast Cancer

Breast Cancer

China
Shulov Innovate for Science Ltd. 2012

Completed

Safety and Tolerability Study of ZEP-3 Cream (0.1% and 1.0%), Administered Topically In Healthy Volunteers

Healthy

Israel
GMP Endotherapeutics

Completed

Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

United States
Duke University
American Heart Association

Completed

STARBRITE: A Randomized Pilot Trial of BNP-Guided Therapy in Patients With Advanced Heart Failure (STARBRITE)

Congestive Heart Failure
Biosite

Terminated

Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT)

Heart Failure

United States
Danish Headache Center

Completed

Hemodynamic and Headache-Inducing Effect of Intravenous Vasoactive Intestinal Peptide in Migraineurs

Migraine | Headache | Ultrasonography, Doppler, Transcranial | Vasoactive Intestinal Peptide

Denmark
Chandrikha Chandrasekhara
TerSera Therapeutics LLC

Withdrawn

Prospective Assessment of Patients With Neuroendocrine Tumors and Current or Prior History of Carcinoid Syndrome or Diarrhea Undergoing Peptide Receptor Radionuclide Therapy With or Without Telotristat Ethyl (NET-PACS)

Diarrhea | Neuroendocrine Tumors | Carcinoid Syndrome

United States
Universidad Nacional de Colombia
Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS) and other collaborators

Completed

Personalized Vaccine for Cancer Immunotherapy

Breast Cancer Female

Colombia
Beijing Doing Biomedical Co., Ltd.

Unknown

Clinical Safety and Preliminary Efficacy of MUC1-DC-CTL Treatment in Stage IV Gastric Cancer.

Gastric Cancer

China
Mibelle AG

Withdrawn

Prophylactic Effect of a CANDIDA Mouthwash, Containing the Curolox™ Peptide

Erosion of Teeth, Unspecified

Switzerland
National Cancer Institute (NCI)

Completed

A Phase I Study of gp100 Human Melanoma Peptide Vaccine With Incomplete Freund's Adjuvant

Melanoma

United States
Herlev Hospital
University of Copenhagen; The Danish Medical Research Council; The Danish Diabetes...

Completed

GIP, GLP-1 and GLP-2 in Type 2 Diabetic Hyperglucagonemia

Type 2 Diabetes Mellitus

Denmark
Uppsala University
Karolinska Institutet; University of Copenhagen

Completed

GIP and GLP-1 on Gastric Emptying, Appetite and Insulin-glucose (GIP-GLP-gas)

Physiology | Gastroenterology | Endocrinology

Sweden
Vanderbilt University

Completed

Pharmacogenetics of Ace Inhibitor-Associated Angioedema

Hypertension | Diabetes Type 2

United States
Stony Brook University
FDA Office of Orphan Products Development; State University of New York

Completed

Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis

Sepsis | Respiratory Distress Syndrome | Respiratory Distress Syndrome, Adult

United States
LI ZHAO

Completed

Acute Effects of rhBNP in Patients With PH Associated With Acute Exacerbation of Chronic Pulmonary Disease

Pulmonary Hypertension

China
University of Michigan

Completed

Phase 1A Study of the Safety of KSP/QRH Dimer

Healthy Adults

United States
Universidad Católica de Honduras
Pontificia Universidad Catolica de Chile

Completed

Safety and Efficacy of Thymic Peptides in the Treatment of Hospitalized COVID-19 Patients in Honduras

COVID-19

Honduras
Shanghai Jiao Tong University School of Medicine

Completed

Effects of rhBNP in Pediatrics After Corrective Repair of Tetralogy Of Fallot

Congenital Heart Defects | Tetralogy Of Fallot

China
Janssen Pharmaceutical K.K.

Completed

An Exploratory Study of Nesiritide in Participants With Acute Heart Failure

Heart Failure, Congestive

Japan
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Preventing Cytomegalovirus in Healthy Participants

Nonneoplastic Condition

United States
Mayo Clinic

Terminated

B-type Natriuretic Peptide (BNP) in Human Hypertension

Hypertension Stage 1

United States
Universidad Nacional de Colombia
Fundación Salud de los Andes

Not yet recruiting

Personalized Vaccine for TNBC Immunotherapy (TEBICA003 TNBC)

Breast Cancer Female

Colombia
Ludwig Institute for Cancer Research
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Safety of Peptide Vaccination for Patients With Myelodysplastic Syndrome

Myelodysplastic Syndrome (MDS)

United States
Inge Marie Svane

Completed

IDO Peptid Vaccination for Stage III-IV Non Small-cell Lung Cancer Patients. (IDOvaccine)

NSCLC | Lung Cancer

Denmark
BioMarin Pharmaceutical

Completed

A Study to Evaluate Safety and Tolerability of BMN 111 Administered to Healthy Adult Volunteers

Achondroplasia

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Cytomegalovirus Vaccine in Healthy Participants

Precancerous/Nonmalignant Condition

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects

HIV Infections

United States
Craig L Slingluff, Jr
National Cancer Institute (NCI)

Terminated

Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

United States
National Cancer Institute (NCI)

Completed

Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery

Stage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Melanoma | Stage IIIC Cutaneous Melanoma AJCC v7 | Mucosal Melanoma | Iris Melanoma | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7 | Stage IV Uveal Melanoma AJCC v7 | Medium/Large Size Posterior Uveal Melanoma | Recurrent... and other conditions

United States

Search clinical trials for: Glucagonlike peptide

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations